Samik Basu

Company: Cabaletta Bio

Job title: Chief Scientific Officer

Seminars:

Developing CD19 CAR-T for Autoimmune Disease & Early Clinical Insights 9:20 am

Leveraging pre-existing experience with CAR-T in oncology and HSCT in autoimmune disease for CAR-T in autoimmune disease Designing the optimal CD19 CAR-T for autoimmune disease Discussing early clinical insights from SLE patients treated with CD19 CAR-T cellsRead more

day: Conference Day Two

Industry Leader’s Fireside Chat: The Promises & Challenges of Cell Therapy for Autoimmune Disease 9:10 am

What learnings can we take from the success of CAR-T and other cell therapies treating cancer? How do we translate these learnings into the field of autoimmunity? How will we overcome key challenges that are currently limiting clinical progression? What are the pros and cons of different cell therapy modalities (CAR-T, Treg, MSC etc.)?Read more

day: Conference Day One